Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal

Gavin C. Harewood, K. Shiva Kumar, Jonathan E. Clain, Michael J. Levy, Heidi Nelson

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Depth of invasion beyond the muscularis propria (MP) by T3 rectal cancer can vary. The purpose of the present paper was to determine if depth of invasion beyond MP, as assessed by preoperative endoscopic ultrasound (EUS), can predict tumor recurrence in patients with T3 rectal tumors. Methods: Patients with TSNxMO rectal cancer, as determined by EUS, who underwent surgical resection (without preoperative neoadjuvant therapy) were reviewed by two blinded endosonographers. Tumors were classified as minimally invasive T3 (invasion ≤ 2 mm beyond MP by EUS) and advanced T3 disease (invasion > 2 mm). Results: Forty-two patients withT3 rectal tumors underwent surgical resection without receiving preoperative neoadjuvant therapy, of whom 14 had minimally invasive T3 and 28 had advanced T3 disease, as determined by preoperative EUS. Median follow up was 19 months. Tumor recurrence rates in minimally invasive and advanced T3 tumors were 14.3% and 39.3%, respectively, P = 0.02 (log-rank test). Adjusting for nodal status and postoperative adjuvant therapy administration, Cox proportional hazards model demonstrated advanced T3 disease (by EUS) to predict tumor recurrence, hazard ratio, 2.28 (95% confidence interval: 1.17-5.81), P= 0.01. Conclusions: All T3 rectal tumors are not equal, with minimally invasive disease carrying a more favorable prognosis. By discriminating minimally invasive from advanced T3 disease, preoperative EUS provides important prognostic information. Further subclassification of T3 tumors, based on preoperative EUS staging, should be considered to enhance selection of patients for neoadjuvant therapy.

Original languageEnglish (US)
Pages (from-to)750-755
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume19
Issue number7
DOIs
StatePublished - 2004

Fingerprint

Rectal Neoplasms
Neoadjuvant Therapy
Neoplasms
Recurrence
Proportional Hazards Models
Patient Selection
Confidence Intervals

Keywords

  • Endoscopic ultrasound
  • Endoscopy
  • Rectal cancer
  • Tumor staging

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound : All T3 rectal cancers are not equal. / Harewood, Gavin C.; Kumar, K. Shiva; Clain, Jonathan E.; Levy, Michael J.; Nelson, Heidi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 19, No. 7, 2004, p. 750-755.

Research output: Contribution to journalArticle

@article{44e3b110cc1b4ec5a84b12a669eab7b3,
title = "Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal",
abstract = "Background: Depth of invasion beyond the muscularis propria (MP) by T3 rectal cancer can vary. The purpose of the present paper was to determine if depth of invasion beyond MP, as assessed by preoperative endoscopic ultrasound (EUS), can predict tumor recurrence in patients with T3 rectal tumors. Methods: Patients with TSNxMO rectal cancer, as determined by EUS, who underwent surgical resection (without preoperative neoadjuvant therapy) were reviewed by two blinded endosonographers. Tumors were classified as minimally invasive T3 (invasion ≤ 2 mm beyond MP by EUS) and advanced T3 disease (invasion > 2 mm). Results: Forty-two patients withT3 rectal tumors underwent surgical resection without receiving preoperative neoadjuvant therapy, of whom 14 had minimally invasive T3 and 28 had advanced T3 disease, as determined by preoperative EUS. Median follow up was 19 months. Tumor recurrence rates in minimally invasive and advanced T3 tumors were 14.3{\%} and 39.3{\%}, respectively, P = 0.02 (log-rank test). Adjusting for nodal status and postoperative adjuvant therapy administration, Cox proportional hazards model demonstrated advanced T3 disease (by EUS) to predict tumor recurrence, hazard ratio, 2.28 (95{\%} confidence interval: 1.17-5.81), P= 0.01. Conclusions: All T3 rectal tumors are not equal, with minimally invasive disease carrying a more favorable prognosis. By discriminating minimally invasive from advanced T3 disease, preoperative EUS provides important prognostic information. Further subclassification of T3 tumors, based on preoperative EUS staging, should be considered to enhance selection of patients for neoadjuvant therapy.",
keywords = "Endoscopic ultrasound, Endoscopy, Rectal cancer, Tumor staging",
author = "Harewood, {Gavin C.} and Kumar, {K. Shiva} and Clain, {Jonathan E.} and Levy, {Michael J.} and Heidi Nelson",
year = "2004",
doi = "10.1111/j.1440-1746.2004.03356.x",
language = "English (US)",
volume = "19",
pages = "750--755",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound

T2 - All T3 rectal cancers are not equal

AU - Harewood, Gavin C.

AU - Kumar, K. Shiva

AU - Clain, Jonathan E.

AU - Levy, Michael J.

AU - Nelson, Heidi

PY - 2004

Y1 - 2004

N2 - Background: Depth of invasion beyond the muscularis propria (MP) by T3 rectal cancer can vary. The purpose of the present paper was to determine if depth of invasion beyond MP, as assessed by preoperative endoscopic ultrasound (EUS), can predict tumor recurrence in patients with T3 rectal tumors. Methods: Patients with TSNxMO rectal cancer, as determined by EUS, who underwent surgical resection (without preoperative neoadjuvant therapy) were reviewed by two blinded endosonographers. Tumors were classified as minimally invasive T3 (invasion ≤ 2 mm beyond MP by EUS) and advanced T3 disease (invasion > 2 mm). Results: Forty-two patients withT3 rectal tumors underwent surgical resection without receiving preoperative neoadjuvant therapy, of whom 14 had minimally invasive T3 and 28 had advanced T3 disease, as determined by preoperative EUS. Median follow up was 19 months. Tumor recurrence rates in minimally invasive and advanced T3 tumors were 14.3% and 39.3%, respectively, P = 0.02 (log-rank test). Adjusting for nodal status and postoperative adjuvant therapy administration, Cox proportional hazards model demonstrated advanced T3 disease (by EUS) to predict tumor recurrence, hazard ratio, 2.28 (95% confidence interval: 1.17-5.81), P= 0.01. Conclusions: All T3 rectal tumors are not equal, with minimally invasive disease carrying a more favorable prognosis. By discriminating minimally invasive from advanced T3 disease, preoperative EUS provides important prognostic information. Further subclassification of T3 tumors, based on preoperative EUS staging, should be considered to enhance selection of patients for neoadjuvant therapy.

AB - Background: Depth of invasion beyond the muscularis propria (MP) by T3 rectal cancer can vary. The purpose of the present paper was to determine if depth of invasion beyond MP, as assessed by preoperative endoscopic ultrasound (EUS), can predict tumor recurrence in patients with T3 rectal tumors. Methods: Patients with TSNxMO rectal cancer, as determined by EUS, who underwent surgical resection (without preoperative neoadjuvant therapy) were reviewed by two blinded endosonographers. Tumors were classified as minimally invasive T3 (invasion ≤ 2 mm beyond MP by EUS) and advanced T3 disease (invasion > 2 mm). Results: Forty-two patients withT3 rectal tumors underwent surgical resection without receiving preoperative neoadjuvant therapy, of whom 14 had minimally invasive T3 and 28 had advanced T3 disease, as determined by preoperative EUS. Median follow up was 19 months. Tumor recurrence rates in minimally invasive and advanced T3 tumors were 14.3% and 39.3%, respectively, P = 0.02 (log-rank test). Adjusting for nodal status and postoperative adjuvant therapy administration, Cox proportional hazards model demonstrated advanced T3 disease (by EUS) to predict tumor recurrence, hazard ratio, 2.28 (95% confidence interval: 1.17-5.81), P= 0.01. Conclusions: All T3 rectal tumors are not equal, with minimally invasive disease carrying a more favorable prognosis. By discriminating minimally invasive from advanced T3 disease, preoperative EUS provides important prognostic information. Further subclassification of T3 tumors, based on preoperative EUS staging, should be considered to enhance selection of patients for neoadjuvant therapy.

KW - Endoscopic ultrasound

KW - Endoscopy

KW - Rectal cancer

KW - Tumor staging

UR - http://www.scopus.com/inward/record.url?scp=3242795075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242795075&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2004.03356.x

DO - 10.1111/j.1440-1746.2004.03356.x

M3 - Article

C2 - 15209620

AN - SCOPUS:3242795075

VL - 19

SP - 750

EP - 755

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 7

ER -